APLAR Perspectives

Content

• 

  The dynamic evolution of rheumatology in Korea

  During the past 35 years rheumatology in Korea has progressed remarkably swiftly in terms of academic activity, clinical practice and health care. However, the future of rheumatology in Korea requires continued efforts by rheumatologists, as well as government support, to enable translation of advances in basic research to clinical practice and promote the development of new treatments and technologies targeting rheumatic diseases.

  • Ho-Youn Kim
  • Yeong-Wook Song

  Science and Society17 Dec 2015 Nature Reviews Rheumatology
• 

  Successes, challenges and developments in Australian rheumatology

  In this APLAR series article, the unique pros and cons of rheumatology services and research in Australia are analysed. With the aim of optimizing the experience of patients, an improved model is proposed for data sharing in the healthcare system.

  • Eric F. Morand
  • Michelle T. Leech

  Science and Society10 Mar 2015 Nature Reviews Rheumatology
• 

  Genetics of rheumatoid arthritis in Asia—present and future

  Genetic factors play an important part in the disease heterogeneity observed in patients with rheumatoid arthritis (RA). Genome-wide association studies (GWAS) have linked common single-nucleotide polymorphisms with the risk of developing RA, but have also highlighted the genetic heterogeneity between Asian and European patients with this disease. In this Perspectives article, the authors discuss recent advances from GWAS in Asian patients with RA, and suggest that better knowledge of the interface between genetic and environmental factors could help our understanding of the disease.

  • Kazuhiko Yamamoto
  • Yukinori Okada
  • Yuta Kochi

  Opinion10 Feb 2015 Nature Reviews Rheumatology
• 

  A new look at rheumatology in China—opportunities and challenges

  Funding and support for research and development in China is expanding at a rapid rate. In this APLAR Perspectives article, this growth is highlighted by advances in the field of rheumatology that have been catalysed by an increase in funding for Chinese rheumatology and by international partnerships.

  • Zhan-guo Li

  Science and Society20 Jan 2015 Nature Reviews Rheumatology
• 

  Rheumatology in India—quo vadis?

  The treatment of rheumatic diseases in India is beset with several problems, such as a high patient load and grossly inadequate number of trained rheumatology specialists. In this Perspectives article, Handa explores the most pressing challenges and suggests helpful approaches to overcome the limitations in rheumatology care in India.

  • Rohini Handa

  Science and Society4 Nov 2014 Nature Reviews Rheumatology

• An insight into rheumatology in Thailand

  Rheumatic diseases are a common health-care problem in Thailand. Patient care is influenced not only by differences in the prevalence, clinical traits and genetic variants of these diseases in Thailand compared with other countries, but by the country's health-care systems, availability of medicine and physicians, and rheumatology training, education and research. The author provides his expert view of the current challenges and barriers, recent successes and future prospects of rheumatology in Thailand.

  • Worawit Louthrenoo

  Science and Society9 Sep 2014 Nature Reviews Rheumatology